AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Drugs - Where Will It All Lead?
Drug companies can no longer afford to develop new drugs in the united states for patients with rare diseases. Increasingly, they must rely on drugs with high volume sales. Four drug firms have already gone out of business and the number of new drugs introduced is going down. We simply haven't learned from experience.